Skip to main content
. Author manuscript; available in PMC: 2008 Jun 21.
Published in final edited form as: Expert Rev Cardiovasc Ther. 2006 Nov;4(6):813–825. doi: 10.1586/14779072.4.6.813

Box 2.

Causes of ADAMTS13 deficiency

Autoimmune antibodies
Inhibitory IgG antibody of ADAMTS13 causes profound ADAMTS13 deficiency in acquired TTP
The level of the inhibitory antibody is low (< 10 units/mL) in most cases.
The prevalence and significance of non-inhibitory antibodies of ADAMTS13 remain unclear.
Mutations of the ADAMTS13 gene
Patients with hereditary TTP are doubly heterozygous or homozygous of mutant alleles. No abnormal phenotypes have been identified in carriers of single mutant alleles.
More than 65 different mutations have been identified, including nonsense, missense, deletion, and splicing. The mutations span the entire spectrum of ADAMTS13 domain structure.
At least 27 polymorphisms have been detected. Certain cis-combinations of polymorphisms may compromise protease secretion/activity.
Genotype-phenotype correlation is unclear because only a few of the mutations have been detected recurrently in more than one pedigree.

Ig: immunoglobulin; TTP: thrombotic thrombocytopenic purpura.